S100β as a Serum Marker in Endocrine Resistant Breast Cancer

BMC Medicine - United Kingdom
doi 10.1186/s12916-017-0836-2
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer

Science Translational Medicine
Medicine
2014English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2001English

Postmenopausal Breast Cancer: A Best Endocrine Strategy?

The Lancet
Medicine
2015English

Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer

Journal of Molecular Biomarkers & Diagnosis
2013English

Serum Anti-P53 Antibody as a Tumour Marker for Colorectal Cancer Screening

ecancermedicalscience
Cancer ResearchOncology
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy